News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Andrea Menicucci

Articles by Andrea Menicucci

26 Prediction of Chemotherapy Benefit by MammaPrint® in Patients With HR+HER2- Early-Stage Breast Cancer From Real-World Evidence Studies

26 Prediction of Chemotherapy Benefit by MammaPrint® in Patients With HR+HER2- Early-Stage Breast Cancer From Real-World Evidence Studies

ByWilliam Audeh, MD,Harshini Ramaswamy,Andrea Menicucci

July 27th 2024

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

ByWilliam Audeh, MD,Nicole Chmielewski-Stivers,Harshini Ramaswamy,Andrea Menicucci

June 30th 2024

Latest Updated Articles

Trending on CancerNetwork

FDA OKs Pembrolizumab/EV Combo in Muscle Invasive Bladder Cancer

EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process

Five Gastrointestinal Cancer Abstracts You May Have Missed at ESMO GI 2026

FDA Approves Subcutaneous Isatuximab in Multiple Myeloma

FDA Rejects Rivoceranib/Camrelizumab in First-Line Unresectable HCC